Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

February 28, 2011

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Gillespie Geoffrey C

2. Date of Event Requiring Statement (Month/Day/Year)
03/15/2024

3. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [OFIX]

(Last)

(First)

(Middle)

3451 PLANO PARKWAY

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
CAO

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

LEWISVILLE, TX 75056

6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	37,203 ⁽¹⁾	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	⁽²⁾	01/05/2030	Common Stock	11,205	$ 20.9	D
Employee Stock Option (Right to Buy)	⁽³⁾	01/08/2031	Common Stock	10,967	$ 13.29	D

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Gillespie Geoffrey C 3451 PLANO PARKWAY LEWISVILLE, TX 75056			CAO

Signatures

/s/ Geoffrey C. Gillespie		03/19/2024
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Consist of 1,692 share of Common Stock directly owned by Reporting Person and 35,511 unvested restricted stock units, of which, 101 units will vest on December 15, 2024, 291 units will vest on April 1, 2024, 292 units will vest on April 1, 2025, 615 units will vest on February 1, 2025, 615 units will vest on February 1, 2026, 1,552 units will vest on January 5, 2025, 1,552 units will vest on January 5, 2026, 2,459 units will vest on January 31, 2025, 23,331 units will vest on October 15, 2025, 1,567 units will vest on January 8, 2025, 1,568 units will vest on January 8, 2026, and 1,568 units will vest on January 8, 2027.
(2)	The options were granted on January 5, 2023 and will vest and become exercisable with respect to one-third (1/3rd) or the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.
(3)	The options were granted on January 8, 2024 and will vest and become exercisable with respect to one-third (1/3rd) or the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.